Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.

Saved in:
Bibliographic Details
Title: Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
Authors: Diedrich JD; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Dong Q; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Ferguson DC; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Bergeron BP; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Autry RJ; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA., Qian M; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Yang W; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Smith C; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Papizan JB; Department of Cell and Molecular biology and Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN, USA., Connelly JP; Department of Cell and Molecular biology and Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN, USA., Hagiwara K; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Crews KR; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Pruett-Miller SM; Department of Cell and Molecular biology and Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN, USA., Pui CH; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Yang JJ; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Relling MV; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Evans WE; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Savic D; Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN, USA. daniel.savic@stjude.org.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. daniel.savic@stjude.org.; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA. daniel.savic@stjude.org.
Source: Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1867.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-024-02291-x